Clinical Trial Update: ProsTIC Registry of Men Treated With PSMA Theranostics

View source ↗

Summary

This entry provides an update on the ProsTIC Registry, a study of men treated with PSMA theranostics for prostate cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Status: RECRUITING